The WACC of BioXcel Therapeutics Inc (BTAI) is 6.6%.
| Range | Selected | |
| Cost of equity | 11.20% - 19.40% | 15.30% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 6.1% - 7.2% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.59 | 2.6 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11.20% | 19.40% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 5.77 | 5.77 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 6.1% | 7.2% |
| Selected WACC | 6.6% | |